AAG
COGT icon

Armstrong Advisory Group’s Cogent Biosciences COGT Stock Holding History

Armstrong Advisory Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Hold
272
– – ﹤0.01% 702
2026
Q1 		$10.5K Buy
+272
New +$10K ﹤0.01% 680

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Armstrong Advisory Group's COGT Position: Q2 2026 in Review

Armstrong Advisory Group held its Cogent Biosciences (COGT) position steady in Q2 2026 at 272 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Armstrong Advisory Group first reported a position in COGT in Q1 2026 and has held it in 2 quarters since. 18 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Armstrong Advisory Group held 272 shares of Cogent Biosciences worth $10.5K as of Q2 2026.
  • Armstrong Advisory Group left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #702 holding.
  • Armstrong Advisory Group first reported a position in Cogent Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 18 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.